These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21765969)

  • 1. Merging Structural Motifs of Functionalized Amino Acids and α-Aminoamides Results in Novel Anticonvulsant Compounds with Significant Effects on Slow and Fast Inactivation of Voltage-gated Sodium Channels and in the Treatment of Neuropathic Pain.
    Wang Y; Wilson SM; Brittain JM; Ripsch MS; Salomé C; Park KD; White FA; Khanna R; Kohn H
    ACS Chem Neurosci; 2011 Jun; 2(6):317-322. PubMed ID: 21765969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamide and safinamide.
    Park KD; Yang XF; Dustrude ET; Wang Y; Ripsch MS; White FA; Khanna R; Kohn H
    ACS Chem Neurosci; 2015 Feb; 6(2):316-30. PubMed ID: 25418676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric derivatives of functionalized amino acids and α-aminoamides: compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels.
    Torregrosa R; Yang XF; Dustrude ET; Cummins TR; Khanna R; Kohn H
    Bioorg Med Chem; 2015 Jul; 23(13):3655-66. PubMed ID: 25922183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of novel derivatives of the antiepileptic drug lacosamide that exhibit far greater enhancement in slow inactivation of voltage-gated sodium channels.
    Wang Y; Park KD; Salome C; Wilson SM; Stables JP; Liu R; Khanna R; Kohn H
    ACS Chem Neurosci; 2011 Feb; 2(2):90-106. PubMed ID: 21532923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation.
    Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C
    J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
    Errington AC; Stöhr T; Heers C; Lees G
    Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of lacosamide affinity bait agents that exhibit potent voltage-gated sodium channel blocking properties.
    Park KD; Yang XF; Lee H; Dustrude ET; Wang Y; Khanna R; Kohn H
    ACS Chem Neurosci; 2013 Mar; 4(3):463-74. PubMed ID: 23509982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
    Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
    Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.
    Sheets PL; Heers C; Stoehr T; Cummins TR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):89-99. PubMed ID: 18378801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of anesthetic and nonanesthetic cyclobutanes on neuronal voltage-gated sodium channels.
    Ratnakumari L; Vysotskaya TN; Duch DS; Hemmings HC
    Anesthesiology; 2000 Feb; 92(2):529-41. PubMed ID: 10691242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neuronal Na
    Peng YS; Wu HT; Lai YC; Chen JL; Yang YC; Kuo CC
    Neuropharmacology; 2020 Nov; 179():108266. PubMed ID: 32853658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels.
    Ilyin VI; Hodges DD; Whittemore ER; Carter RB; Cai SX; Woodward RM
    Br J Pharmacol; 2005 Mar; 144(6):801-12. PubMed ID: 15778702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States.
    Jo S; Bean BP
    Mol Pharmacol; 2017 Apr; 91(4):277-286. PubMed ID: 28119481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na
    Holtkamp D; Opitz T; Niespodziany I; Wolff C; Beck H
    Epilepsia; 2017 Jan; 58(1):27-41. PubMed ID: 27864845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lidocaine reduces the transition to slow inactivation in Na(v)1.7 voltage-gated sodium channels.
    Sheets PL; Jarecki BW; Cummins TR
    Br J Pharmacol; 2011 Sep; 164(2b):719-30. PubMed ID: 21232038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats.
    Remy S; Urban BW; Elger CE; Beck H
    Eur J Neurosci; 2003 Jun; 17(12):2648-58. PubMed ID: 12823472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation.
    Wang Y; Brittain JM; Jarecki BW; Park KD; Wilson SM; Wang B; Hale R; Meroueh SO; Cummins TR; Khanna R
    J Biol Chem; 2010 Aug; 285(33):25296-307. PubMed ID: 20538611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merging the structural motifs of functionalized amino acids and alpha-aminoamides: compounds with significant anticonvulsant activities.
    Salomé C; Salomé-Grosjean E; Stables JP; Kohn H
    J Med Chem; 2010 May; 53(9):3756-71. PubMed ID: 20394379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of batrachotoxin-modified Na+ channels in GH3 cells. Characterization and pharmacological modification.
    Wang GK; Wang SY
    J Gen Physiol; 1992 Jan; 99(1):1-20. PubMed ID: 1311019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of voltage-gated Na⁺ channels by the synthetic cannabinoid ajulemic acid.
    Foadi N; Berger C; Pilawski I; Stoetzer C; Karst M; Haeseler G; Wegner F; Leffler A; Ahrens J
    Anesth Analg; 2014 Jun; 118(6):1238-45. PubMed ID: 24755846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.